Bundling and the QIP. Jay B. Wish, MD NKF of Illinois 15 th Annual Interdisciplinary Nephrology Conference October 24, 2014
|
|
|
- Shon Carr
- 8 years ago
- Views:
Transcription
1 Bundling and the QIP Jay B. Wish, MD NKF of Illinois 15 th Annual Interdisciplinary Nephrology Conference October 24, 2014
2 Who Pays for Chronic Dialysis? Short answer you (the taxpayer) do Legislative basis: Public law , Social Security Act of 1972, Medicare eligibility for patients with ESRD after 3 month waiting period, provided they have paid into social security system for 20 quarters or are a dependent of someone who has. Medicare pays 80%, patient needs co-insurance to pay other 20%.
3 Driving Factors for Revision of Medicare Reimbursement for ESRD RCTs failed to show improved outcomes when ESAs dosed to higher Hb/Hct levels in patients with kidney disease CHOIR and CREATE in CKD patients Normal Hct Study in HD patients Costs of ESAs in ESRD patients escalating to >$2 billion/year High percentage of dialysis patients (50% in 2006) with Hb >12 g/dl (upper limit per KDOQI guidelines) Previous payment policy did not provide financial incentive to constrain ESA use CMS indicates Centers for Medicare & Medicaid Services; ESRD, end-stage renal disease; PPS, prospective payment system; MIPPA, Medicare Improvement for Patients and Providers; CHOIR, The Correction of Hemoglobin and Outcomes in Renal Insufficiency; CREATE, The Cardiovascular risk Reduction by Early Anemia Treatment with Epoetin Beta; CKD, chronic kidney disease; ESA, erythropoiesis-stimulating agent; Hb, hemoglobin; Hct, hematocrit; HD, hemodialysis.
4 Previous Medicare Payment Policies 60% of what CMS paid was for the dialysis treatment itself and included labs ($4,788.5*) 40% of what CMS paid was for separately billed items Parenteral drugs and biologicals ($2,763.8*) Additional lab services ($333.2*) Certain supplies ($40.2*) Congress called upon CMS to develop a plan to bundle ESAs and other separately billable drugs into a single case-mix adjusted payment to dialysis facilities Changes ESAs from a profit center to a cost center for dialysis providers Encourages facilities to curtail ESA use *Total Medicare allowable payments, in millions, CMS indicates Centers for Medicare & Medicaid Services; ESA, erythropoiesis-stimulating agent.
5 Major Provisions of Final Rule Base payment rate of $ Excludes adjustments (all positive except for wage index) Average adjustment 5.94% higher Per treatment unit of payment Up to 3 treatments per week (unless medically justified) May discourage more frequent home HD modalities Beneficiary/coinsurance amount is 20% of the total ESRD PPS payment after all adjustments HD indicates hemodialysis; ESRD, end-stage renal disease; PPS, prospective payment system.
6 Major Provisions of Final Rule (cont d) Patient level payment adjusters Facility level adjusters Low volume (<4000 treatments/year) Geographic wage index Inclusion of all ESRD related drugs Previously separately billable IV drugs given on dialysis and their oral equivalents Includes all antibiotics administered on dialysis for an ESRD-related indication Excludes all vaccines BSA indicates body surface area, BMI, body mass index, RRT, renal replacement therapy, ESRD, end-stage renal disease; MIPPA, Medicare Improvements for Patients and Providers Act.
7 Major Provisions of Final Rule (cont d) 2% withhold for payment for performance Can earn all or part back based on total performance score All ESRD-related lab tests are included in the bundled payment whether or not they are drawn in the dialysis facility URR indicates urea reduction ratio; MCP, monthly capitation payment.
8 Case Mix Adjusters Characteristic Adjuster Age BSA per 0.1 m 2 over BMI < Characteristic Adjuster Pericarditis in <3 months Bact. pneumonia in <3 mo GI bleed in <3 months Hereditary anemia Myelodysplastic syndrome Monoclonal gammopathy Onset of dialysis <4 months Facility <4000 treatments/yr A facility can adjust for the age and patient size characteristics and for EITHER one of the comorbidity characteristics OR the new onset of dialysis, but not BOTH
9 Facility Level Adjustments Wage index applies to the labor share of the bundle (41.7%) Decreases wage index floor from 90% to 60% Low volume adjustment <4000 treatments x 3 years No change in ownership Only applies to claims for patients >18 years old MIPPA indicates Medicare Improvements for Patients and Providers Act.
10 Self-Dialysis Training $33.38 can be added on to the ESRD PPS payment for each self-dialysis training session (increased by 50% beginning in 2014) This amount is adjusted by the geographical area wage index ESRD facilities cannot receive the self-training adjustment and the 4-month onset of dialysis payment on the same patient for the same session Self-training add-on is capped at 15 treatments for PD and 25 treatments for hemodialysis
11 Outlier Policy Outlier services limited to items previously separately billable under Medicare Parts B & D including drugs and lab tests Adult patient qualifies for additional outlier payment if adjusted cost of separately billable items exceeds donut hole of $ Excess is reimbursed at 80% CMS estimates that 5.3% of adult claims and 6.7% of pediatric claims will qualify for outlier payment MAP indicates Medicare allowable payment; ASP, average selling price.
12 ESRD QIP Value-Based Purchasing (VBP) Transition : Quantity of services provided to beneficiaries to Quality of those services delivered Advancing the National Quality Strategy and 3 part aim 6 domains (National Priorities of the NQS) Safety, Patient (Caregiver) centered care, Clinical care, Care coordination, Population health, Cost reduction Paying for quality healthcare is no longer the payment system of the future; it s the payment system of today. The ESRD QIP is the leading edge of payment reform and can serve as an example to the healthcare system.
13 ESRD QIP National Priorities
14 ESRD QIP Performance Year vs. Payment Year Performance Year Payment Year * *first time that performance standards, achievement thresholds and benchmarks have all been published PRIOR to the beginning of the Performance Year
15 QIP Measures PY Measure Hgb <10 Yes Hgb >12 Yes Yes Yes Yes URR >65% Yes Yes Yes Kt/V >1.2 Yes High AVF Yes Yes Low CVC >90d Yes Yes Pediatric HD adequacy Yes PD adequacy Yes ICH-CAHPS administration Yes NHSN reporting of infections Yes Anemia reporting Yes Mineral metabolism reporting Yes
16 QIP Measures PY 2016 Clinical Measures Anemia Management: Hgb > 12 Hemodialysis Adequacy: Minimum delivered hemodialysis dose Hypercalcemia NHSN Bloodstream Infection Monitoring Peritoneal Dialysis Adequacy: Delivered dose above minimum Pediatric Hemodialysis Adequacy: Minimum spkt/v Vascular Access Type: Arterial Venous (AV) Fistula Vascular Access Type: Catheter >= 90 days
17 QIP Measures PY 2016 Reporting Measures Anemia Management Reporting ICH CAHPS Administration Mineral Metabolism Reporting
18 Proposed QIP Measures PY 2017 Clinical Measures: Vascular Access Type: Arterial Venous (AV) Fistula Vascular Access Type: Catheter >= 90 days Hemodialysis Adequacy: Minimum delivered hemodialysis dose Peritoneal Dialysis Adequacy: Delivered dose above minimum Pediatric Hemodialysis Adequacy: Minimum spkt/v Hypercalcemia NHSN Bloodstream Infection in Hemodialysis Outpatients Standardized Readmission Ratio
19 Proposed QIP Measures PY 2017 Reporting Measures ICH CAHPS Administration Mineral Metabolism Reporting Anemia Management Reporting
20 Proposed QIP Measures PY 2018 Clinical Measures NHSN Bloodstream Infection in Hemodialysis Outpatients ICH CAHPS Patient Experience of Care Standardized Readmission Ratio Standardized Transfusion Ratio Hemodialysis Adequacy: Minimum delivered hemodialysis dose Peritoneal Dialysis Adequacy: Delivered dose above minimum Pediatric Hemodialysis Adequacy: Minimum spkt/v Pediatric Peritoneal Dialysis Adequacy: Delivered dose above minimum Vascular Access Type: Arterial Venous (AV) Fistula Vascular Access Type: Catheter >= 90 days Hypercalcemia
21 Proposed QIP Measures PY 2018 Proposed Reporting Measures: Mineral Metabolism Reporting Anemia Management Reporting Pain Assessment and Follow-Up Clinical Depression Screening and Follow-Up NHSN Healthcare Personnel Influenza Vaccination
22
23
24
25 Comparisons - National Performance Standards Measure PY 2012 PY 2013 PY 2014 PY 2015 PY 2016 Anemia Management Hemoglobin > 12 g/dl 26% 14% 4% 1% 0% Dialysis Adequacy (URR) 96% 97% 98% NA NA Dialysis Adequacy (Kt/V) Adult HD 93% 93.4% Adult PD 84% 85.7% Pediatric HD 93% 93% Vascular Access Type % Fistula 58% 60% 62.3% % Catheter 14% 13% 10.6% Hypercalcemia 1.7% NHSN Bloodstream Infection CY2014
26 Comparisons - Achievement Thresholds/Benchmarks Measure PY 2014 TH (15 th %) PY2014 BM (90 th %) PY 2015 TH (15 th %) PY 2015 BM (90 th %) PY 2016 TH (15 th %) PY 2016 BM (90 th %) Anemia Management Hgb > 12 g/dl 10% 0% 5% 0% 1.2% 0% Adequacy (URR) 94% 100% NA NA NA NA Adequacy (Kt/V) Adult HD 86% 97% 86% 97.4% Adult PD 63% 94% 67.8% 94.8% Pediatric HD 83% 97% 83% 97.1% VAT % Fistula 46% 74% 47% 75% 49.9% 77% % Catheter 24% 5% 22% 5% 19.9% 1.8% Hypercalcemia 5.4% 0% NHSN CY 2014 CY 2014
27 ESRD QIP Final Rule PY 2016 Total Performance Score (TPS) Scoring methodology identical to the PY 2014/2015 QIP Equally weight the clinical measures as 75 percent of the TPS Equally weight the reporting measures as 25 percent of the TPS Require a facility to have at least one clinical and one reporting measure to receive a TPS Case minimum threshold of 11 cases If the facility reports between 11 and 25 cases during the 12-month performance period, it would be scored based on its raw performance rate plus a favorable reliability adjustment to account for a possible unfavorable skew in the measure rate due to small sample size No adjustment for > 26 cases
28 Comparisons Payment Reduction Scale PY2014 PY2015 PY2016 SCORE REDUCTION SCORE REDUCTION SCORE REDUCTION % % % % % % % % % % % % % % %
29 Comparisons Actual Payment Reductions Percent Penalized Facilities Penalty PY 2012 PY % 16.6% - 1.0% 6% 3.2% 1.5% 7.7% 3.5% 2.0% 0.6% 2.8% Total 30% 10%
30 Rebasing the Bundled Payment (1) The use of ESAs, which decreased by 37% between 2007, when its allowance in the bundle was calculated, to 2012 was due both to changes in the FDA labeling for ESAs in 2011 as well as cost-containment efforts at the facility level. Legislation in 2012 required Medicare to decrease (rebase) the bundled payment for dialysis in 2014 to reflect this decrease in IV drug use, which amounted to a cut of 12% or $30 per treatment.
31
32 Rebasing the Bundled Payment (2) Medicare subsequently decided to phase in this decrease in payment over several years to offset the increase in dialysis payment that would otherwise have occurred with inflation. A 3% reduction from the rebasing would offset an approximately 3% increase in the market basket that determines a facility s costs for 2014 and Legislation in March 2014 provides that the rebasing will result in a 1.25% decrease in the market basket adjustment in 2016 and 2017 and a 1% decrease in the market basket adjustment in 2018, for an aggregate rebasing of 9.5% spread over 5 years.
33 Annual Negative Adjustment to the Market Basket Increase in Dialysis Reimbursement Year Rebasing Adjustment Complete offset of market basket increase (approx. -3%) Complete offset of market basket increase (approx. -3% anticipated) % % % Total Approx. -9.5%
34 New Payment Models for ESRD CMS wants to promote coordination of care, decrease hospitalizations and ER visits, and decrease overall costs of ESRD Current silos of payment (Medicare parts A, B, and D) and of care (dialysis facilities, hospitals, extended care facilities) do not align incentives End-stage renal disease seamless care organizations (ESCOs) are one approach
35 ESCOs Partnership between dialysis facilities, nephrologists, and one other Medicare provider (hospitals, another physician group, extended care facilities) Cost savings are shared by Medicare and the ESCO s participants Savings on hospitalizations (the big ticket item) can be used by dialysis facility to fund innovation and/or offset traditionally thin margins on Medicare and Medicaid patients Incentivizes all partners to work collaboratively to improve quality and decrease costs
36 ESCOs Encourages expansion of the healthcare team to include vascular surgeons, pharmacists, home healthcare providers, skilled nursing facilities, palliative and hospice care Challenges providers to increase patient and caregiver engagement Promotes better pre-esrd care (which saves money once patient is on dialysis) Requires shared EMR
37 Summary and Conclusions The bundled payment system in effect since 2011 is likely the first step towards global capitation of ESRD patients Most dialysis providers require commercial payers to survive since Medicare patient margins are thin and Medicaid margins are negative Rebasing may eliminate the Medicare margin for some providers and foster additional consolidation in an industry in which 2 companies already have a 70% market share Shared savings in an ESCO may be the only way for small and medium-sized dialysis providers that do not have a high percentage of commercial payers to survive
Department of Health and Human Services. Part III
Vol. 80 Friday, No. 215 November 6, 2015 Part III Department of Health and Human Services Centers for Medicare & Medicaid Services 42 CFR Part 413 Medicare Program; End-Stage Renal Disease Prospective
Understanding the PY 2015 ESRD QIP
CMS CROWNWeb Application Understanding the PY 2015 ESRD QIP With the Centers for Medicare & Medicaid Services December 19, 2013 Today s Hosts Janis Grady, RHIT, CPHQ Contract Officer s Representative (COR)
Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality
This document is scheduled to be published in the Federal Register on 07/01/2015 and available online at http://federalregister.gov/a/2015-16074, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
SECURITIES AND EXCHANGE COMMISSION FORM 6-K
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2013 FRESENIUS
Pharmaceuticals Under the Medicare Prospective Payment System. Tracy J. Mayne Senior Director Health Economics & Med Informatics DaVita Inc.
Pharmaceuticals Under the Medicare Prospective Payment System Tracy J. Mayne Senior Director Health Economics & Med Informatics DaVita Inc. This is One Step in the Evolution of Dialysis Reimbursement 6
Medicare Bundling Reimbursement Transition Decision: Opt In or Phase In
Medicare Bundling Reimbursement Transition Decision: Opt In or Phase In Medicare reimbursement for outpatient dialysis is about to undergo the most massive and sweeping change since the inception of the
Interim financial report. 1st quarter 2015
Interim financial report (US-GAAP) 1st quarter 2015 Fresenius Medical Care AG & Co. KGaA Hof an der Saale Germany Page FINANCIAL INFORMATION Management s Discussion and Analysis Forward-looking Statements...
The 2012 Dialysis Care Industry (KGAA)
2013 Quarterly Report Second Quarter Fresenius Medical Care 2013 Second Quarter Overview p. 3 Interim Financial Report Financial Condition and Results of Operations p. 7 Liquidity and Capital Resources
Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and
This document is scheduled to be published in the Federal Register on 06/30/2016 and available online at http://federalregister.gov/a/2016-15188, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
Medicare Claims Processing Manual
Medicare Claims Processing Manual Chapter 8 - Outpatient ESRD Hospital, Independent Facility, and Physician/Supplier Claims Transmittals for Chapter 8 Table of Contents (Rev. 3311, 08-06-15) 10 - General
Administrative Code. Title 23: Medicaid Part 216 Dialysis Services
Title 23: Medicaid Administrative Code Title 23: Medicaid Part 216 Dialysis Services Table of Contents Table of Contents Title 23: Medicaid... 1 Table of Contents... 1 Title 23: Division of Medicaid...
September 6, 2013. Dear Administrator Tavenner:
September 6, 2013 Marilyn Tavenner Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Avenue, SW Washington, DC
Department of Health and Human Services
Thursday, August 12, 2010 Part II Department of Health and Human Services Centers for Medicare & Medicaid Services 42 CFR Parts 410, 413 and 414 Medicare Program; End-Stage Renal Disease Prospective Payment
we are the beneficiaries
August 31, 2013 Marilyn Tavener Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Ave. SW Washington, DC 20201
HEALTH POLICY STATEMENT
Page 1 HEALTH POLICY STATEMENT PREAMBLE The American Nephrology Nurses Association (ANNA) is a national organization of registered nurses practicing in nephrology, which includes but is not limited to
NQF-Endorsed Measures for Renal Conditions, 2015
NQF-Endorsed Measures for Renal Conditions, 2015 TECHNICAL REPORT December 2015 This report is funded by the Department of Health and Human Services under contract HHSM-500-2012-00009I Task Order HHSM-500-T0008
Finances of Home Dialysis: Facility and Physician Payments
Finances of Home Dialysis: Facility and Physician Payments Thomas A. Golper, MD, FACP, FASN Vanderbilt University Medical Center Nashville, TN thomas.golper@vanderbilt.edu Potential Conflict of Interest
Outpatient dialysis services
C h a p t e r6 Outpatient dialysis services R E C O M M E N D A T I O N S 6-1 The Congress should not increase the outpatient dialysis payment rate for calendar year 2015. COMMISSIONER VOTES: YES 17 NO
Interim financial report (US-GAAP) 3rd quarter 2015
Interim financial report (US-GAAP) 3rd quarter 2015 Fresenius Medical Care AG & Co. KGaA Hof an der Saale Germany ii Page FINANCIAL INFORMATION Management s discussion and analysis Forward-looking statements...
Clinical Performance Goals 2010-2011
Clinical Performance Goals 2010-2011 Clinical Performance Goals 2010-2011 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 Clinical Performance Measures... 6 Chapter
DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES
Facility Name: Facility ID: Date: Surveyor Name: Resident Name: Resident ID: Initial Admission Date: Interviewable: Yes No Resident Room: Care Area(s): Use Use this protocol for a sampled resident receiving
CMS Responses to Questions and Comments about the Dialysis Facility Compare (DFC) Star Ratings
CMS Responses to Questions and Comments about the Dialysis Facility Compare (DFC) Star Ratings Throughout the formulation of the DFC Star Ratings methodology, CMS has invited and welcomed questions and
Section I: Defining a Complex Medical Management Model
Section I: Defining a Complex Medical Management Model How should CMS define a complex medical management model, in terms of the applicable medical conditions or diseases, the services furnished, and the
2012 Financial Condition and Results of Operations For dialysis
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2013
Interviewable: Yes No Resident Room: Initial Admission Date: Care Area(s): Use
Facility Name: Facility ID: Date: Surveyor Name: Resident Name: Resident ID: Initial Admission Date: Care Area(s): Interviewable: Yes No Resident Room: Use Use this protocol for a sampled resident receiving
American Kidney Fund 6110 Executive Boulevard Suite 1010 Rockville, Maryland 20852
American Kidney Fund 6110 Executive Boulevard Suite 1010 Rockville, Maryland 20852 301.881.3052 voice 301.881.0898 fax 800.638.8299 toll-free 866.300.2900 Español www.kidneyfund.org Member: CFC 11404 December
Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology*
Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* =Abstracts= Registry committee of Korean Society of Nephrology
Medicare Shared Savings Program (ASN) and the kidney Disease Prevention Project
December 3, 2010 Donald Berwick, MD Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G, Hubert H. Humphrey Building 200 Independence Avenue, SW
Outpatient dialysis services
C h a p t e r6 Outpatient dialysis services R E C O M M E N D A T I O N 6 The Congress should eliminate the update to the outpatient dialysis payment rate for calendar year 2016. COMMISSIONER VOTES: YES
END-STAGE RENAL DISEASE. Medicare Payment Refinements Could Promote Increased Use of Home Dialysis
United States Government Accountability Office Report to the Subcommittee on Health, Committee on Ways and Means, House of Representatives October 2015 END-STAGE RENAL DISEASE Medicare Payment Refinements
Prescription drugs are a critical component of health care. Because of the role of drugs in treating conditions, it is important that Medicare ensures that its beneficiaries have access to appropriate
Guide to the Quarterly Dialysis Facility Compare Preview for April 2016 Report: Overview, Methodology, and Interpretation
Guide to the Quarterly Dialysis Facility Compare Preview for April 2016 Report: Overview, Methodology, and Interpretation February 2016 Table of Contents I. PURPOSE OF THIS GUIDE AND THE QUARTERLY DIALYSIS
Calendar Year 2014 Medicare Physician Fee Schedule Final Rule
Calendar Year 2014 Medicare Physician Fee Schedule Final Rule Non-facility Cap after receiving many negative comments on this issue from physician groups along with the House GOP Doctors Caucus letter,
Medicare Coverage of Kidney Dialysis and Kidney Transplant Services
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Coverage of Kidney Dialysis and Kidney Transplant Services If you have permanent kidney failure, this official government booklet explains the following:
Medicare Coverage of Kidney Dialysis and Kidney Transplant Services
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Coverage of Kidney Dialysis and Kidney Transplant Services If you have permanent kidney failure, this official government booklet explains the following:
September 19, 2012. Dialysis Facility Reimbursement
September 19, 2012 Dialysis Facility Reimbursement Current EGID Reimbursement Dialysis providers are currently reimbursed under the outpatient portion of EGID s facility contract. Network providers receive
CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE
CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE Outline I. Introduction II. Identifying Members with Kidney Disease III. Clinical Guidelines for Kidney Disease A. Chronic Kidney Disease B. End Stage Renal Disease
GAO END-STAGE RENAL DISEASE. CMS Should Monitor Access to and Quality of Dialysis Care Promptly after Implementation of New Bundled Payment System
GAO United States Government Accountability Office Report to Congressional Requesters March 2010 END-STAGE RENAL DISEASE CMS Should Monitor Access to and Quality of Dialysis Care Promptly after Implementation
Home Dialysis Benchmarks Workgroup. Peritoneal Dialysis (PD)
Home Dialysis Benchmarks Workgroup Peritoneal Dialysis (PD) Medical Knowledge Fellows must demonstrate knowledge of established and evolving biomedical, clinical, epidemiological and social behavioral
Value-Based Purchasing Program Overview. Maida Soghikian, MD Grand Rounds Scripps Green Hospital November 28, 2012
Value-Based Purchasing Program Overview Maida Soghikian, MD Grand Rounds Scripps Green Hospital November 28, 2012 Presentation Overview Background and Introduction Inpatient Quality Reporting Program Value-Based
Medicare Value-Based Purchasing Programs
By Jane Hyatt Thorpe and Chris Weiser Background Medicare Value-Based Purchasing Programs To improve the quality of health care delivered to Medicare beneficiaries, the Centers for Medicare and Medicaid
ACOs & ESCOs. Interdisciplinary Nephrology Conference. October 25, 2013
ACOs & ESCOs National Kidney Foundation of Illinois Interdisciplinary Nephrology Conference October 25, 2013 About Me Dan Viaches VP Corp. Development - DaVita 6 Years with DaVita - 5 Years center operations
Stenosis Surveillance 2009
5 Diamond Patient Safety Program Stenosis Surveillance 2009 *This presentation was collaboratively developed by the Mid-Atlantic Renal Coalition (MARC) and the ESRD Network of New England for the 5-Diamond
End Stage Renal Disease (ESRD)
End Stage Renal Disease (ESRD) AN OVERVIEW OF ESRD, TREATMENT COSTS & COVERAGE WSHIP Board Meeting January 14, 2015 Lisa Matthews and Sharon Becker 1 Kidney Disease Facts & Figures 1 in 10 people have
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2005
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2005 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 4, 5 and 6]
The Patient Protection and Affordable Care Act. Implementation Timeline
The Patient Protection and Affordable Care Act Implementation Timeline 2009 Credit to Encourage Investment in New Therapies: A two year temporary credit subject to an overall cap of $1 billion to encourage
August 8, 2014. Dear Dr. Conway:
Dr. Patrick Conway Chief Medical Officer Director, Center for Clinical Standards and Quality Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dear Dr. Conway: I am
Module 6 Medicare for People With End-Stage Renal Disease
Module 6 Medicare for People With End-Stage Renal Disease Section Objectives Define End-Stage Renal Disease (ESRD) Explain Medicare eligibility and enrollment rules Determine what s covered under Medicare
Medicare Home Health Prospective Payment System
Medicare Home Health Prospective Payment System Payment Rule Summary PROPOSED CY 2016 Overview and Resources On July 10, 2015, the Centers for Medicare and Medicaid Services (CMS) published its proposed
Fiscal Year 2016 proposed Inpatient and Long-term Care Hospital policy and payment changes (CMS-1632-P)
Fiscal Year 2016 proposed Inpatient and Long-term Care Hospital policy and payment changes (CMS-1632-P) Date 2015-04-17 Title Fiscal Year 2016 proposed Inpatient and Long-term Care Hospital policy and
Version 12. Module 6: Medicare for People with End-Stage Renal Disease - Alaska
Version 12 Module 6: Medicare for People with End-Stage Renal Disease - Alaska Session Objectives This session will help you understand Medicare for people with End-stage Renal Disease Medicare eligibility
Medical Directorship of a Home Dialysis Unit
Medical Directorship of a Home Dialysis Unit Thomas A. Golper, MD, FACP, FASN Vanderbilt University Medical Center Nashville, TN thomas.golper@vanderbilt.edu Potential Conflict of Interest Disclosure:
Clinical Outcomes and Home Infusion A Way Forward Connie Sullivan, RPh demand side strategy References: National Business Coalition on Health
Clinical Outcomes and Home Infusion A Way Forward Connie Sullivan, RPh Senior Director Education and Data, NHIA Vice President of Research, NHIF Session Objectives Define value based purchasing, and describe
Quarterly Report 1st Quarter 2012. 1st Quarter 2012 Fresenius Medical Care
Quarterly Report Q1 Fresenius Medical Care First Quarter 2012 Overview p. 3 Interim Report of Management s Discussion and Analysis Financial condition and results of operations p. 7 Liquidity and capital
CROWNWeb Data Management Guidelines
Connecting the Pieces CROWNWeb Data Management Guidelines Document Control Document Information Information Sequence Number 0001 Document Type Guidelines Release Number 1.0 Release Date April 15, 2015
Value-Based Payment and Health System Transformation
Value-Based Payment and Health System Transformation National Health Policy Forum Patrick Conway, M.D., MSc CMS Chief Medical Officer Deputy Administrator for Innovation and Quality Director, Center for
Medicare Skilled Nursing Facility Prospective Payment System
Medicare Skilled Nursing Facility Prospective Payment System Payment Rule Brief FINAL RULE Program Year: FFY 2016 Overview and Resources On August 4, 2015, the Centers for Medicare and Medicaid Services
What is Healthcare Reform? Get a view of the future health care system in the US; learn. success factors for healthcare administrators?
What is Healthcare Reform? Get a view of the future health care system in the US; learn about primary resources and tools for the healthcare administrator, and what are the success factors for healthcare
CROWNWeb Data Validation
CMS CROWNWeb Application CROWNWeb Data Validation With Healthcare Management Solutions, LLC November 20, 2014 Note: Computer speakers or headphones are necessary to listen to streaming audio. Streaming
Value-Based Purchasing
Emerging Topics in Healthcare Reform Value-Based Purchasing Janssen Pharmaceuticals, Inc. Value-Based Purchasing The Patient Protection and Affordable Care Act (ACA) established the Hospital Value-Based
Medicare Open Enrollment: What Steps Do Employers Need to Take? Presented by: Donna Dever and Greg Puig August 27, 2015
Medicare Open Enrollment: What Steps Do Employers Need to Take? Presented by: Donna Dever and Greg Puig August 27, 2015 Introduction In this client clinic we will review: What is creditable coverage? What
Pediatric Hemodialysis Access
Pediatric Hemodialysis Access Vincent L. Rowe, M.D., FACS Professor of Surgery Division of Vascular Surgery Keck School of Medicine at University of Southern California NO FINANCIAL DISCLOSURES Outline
what value-based purchasing means to your hospital
Paul Shoemaker what value-based purchasing means to your hospital CMS has devised an intricate way to measure a hospital s quality of care to determine whether the hospital qualifies for incentive payments
All Acute Care Hospitals and End-Stage Renal Disease Clinics. Subject: Billing and Claim Completion Guidelines for Renal Dialysis Services
Indiana Health Coverage Programs P R O V I D E R B U L L E T I N BT200223 MAY 29, 2002 To: All Acute Care Hospitals and End-Stage Renal Disease Clinics Subject: Billing and Claim Completion Guidelines
Medicare and People with End Stage Renal Disease (ESRD)
FACT SHEET Medicare and People with End Stage Renal Disease (ESRD) (I-002) p. 1 of 7 Medicare and People with End Stage Renal Disease (ESRD) If you have end stage renal disease (ESRD) or permanent kidney
survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156
introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected
Medicare Shared Savings Program Quality Measure Benchmarks for the 2015 Reporting Year
Medicare Shared Savings Program Quality Measure Benchmarks for the 2015 Reporting Year Release Notes/Summary of Changes (February 2015): Issued correction of 2015 benchmarks for ACO-9 and ACO-10 quality
June 22, 2012. Dear Administrator Tavenner:
Submitted Electronically Marilyn Tavenner Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue
Medicare Advantage special needs plans
C h a p t e r14 Medicare Advantage special needs plans R E C O M M E N D A T I O N S 14-1 The Congress should permanently reauthorize institutional special needs plans. COMMISSIONER VOTES: YES 16 NO 0
This official government booklet explains: The basics of Medicare How Medicare helps pay for kidney dialysis and kidney transplants Where to get help
This official government booklet explains: The basics of Medicare How Medicare helps pay for kidney dialysis and kidney transplants Where to get help The information in this booklet was correct when it
Hemodialysis Dose and Adequacy
Hemodialysis Dose and Adequacy When kidneys fail, dialysis is necessary to remove waste products such as urea from the blood. By itself, urea is only mildly toxic, but a high urea level means that the
June 25, 2012. Dear Acting Administrator Tavenner,
June 25, 2012 Marilyn B. Tavenner, RN, Acting Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-1588-P P.O. Box 8011 Baltimore, MD 21244-1850
Medicare Inpatient Rehabilitation Facility Prospective Payment System Fiscal Year 2017
Proposed Rule Summary Medicare Inpatient Rehabilitation Facility Prospective Payment System Fiscal Year 2017 May 2016 1 P a g e Table of Contents Overview and Resources... 2 Inpatient Rehabilitation Facility
Section. 37Renal Dialysis Facility
Section 37Renal Dialysis Facility 37 37.1 Enrollment...................................................... 37-2 37.1.1 STAR and STAR+PLUS Program Enrollment.......................... 37-2 37.2 Reimbursement..................................................
Medicare Coverage of Kidney Dialysis & Kidney Transplant Services
CENTERS for MEDICARE & MEDICAID SERVICES Medicare Coverage of Kidney Dialysis & Kidney Transplant Services This official government booklet explains: The basics of Medicare How Medicare helps pay for kidney
CMS Quality Measurement and Value Based Purchasing Programs Kate Goodrich, MD MHS Director, Quality Measurement and Health Assessment Group, CMS
CMS Quality Measurement and Value Based Purchasing Programs Kate Goodrich, MD MHS Director, Quality Measurement and Health Assessment Group, CMS American Urological Association Quality Improvement Summit
End Stage Renal Disease Networks P R O G R A M O V E R V I E W D E C E M B E R 2 0 0 5
End Stage Renal Disease Networks P R O G R A M O V E R V I E W D E C E M B E R 2 0 0 5 End Stage Renal Disease Networks P R O G R A M O V E R V I E W FORUM OF ESRD NETWORKS 1527 Huguenot Road Midlothian,
Medicare Updates Its Dialysis Facility Requirements: 2008 Final ESRD Conditions for Coverage
Medicare Updates Its Dialysis Facility Requirements: 2008 Final ESRD Conditions for Coverage 15-April-2008 AUTHORS: T. Jeffrey Fitzgerald Colleen M. Faddick On April 15, 2008, CMS released the long delayed
TITLE I QUALIFIED ABLE PROGRAMS
Summary of H.R. 647, the Achieving a Better Life Experience (ABLE) Act of 2014 (As Amended and Expected to Be Considered by the House) December 1, 2014 TITLE I QUALIFIED ABLE PROGRAMS Sec. 101. Purposes.
Presented by Kathleen S. Wyka, AAS, CRT, THE AFFORDABLE CA ACT AND ITS IMPACT ON THE RESPIRATORY C PROFESSION
Presented by Kathleen S. Wyka, AAS, CRT, THE AFFORDABLE CA ACT AND ITS IMPACT ON THE RESPIRATORY C PROFESSION At the end of this session, you will be able to: Identify ways RT skills can be utilized for
June 2, 2014. RE: File Code CMS-1608-P. Dear Ms. Tavenner:
. June 2, 2014 Marilyn Tavenner Centers for Medicare & Medicaid Services Room 445-G, Hubert H. Humphrey Building 200 Independence Avenue SW Washington, DC RE: File Code CMS-1608-P Dear Ms. Tavenner: The
QUALITY BEGINNER. PQRS Training Module: QUALITY MEASUREMENT 101. Last Updated: August 2014
QUALITY 01 BEGINNER PQRS Training Module: QUALITY MEASUREMENT 101 Last Updated: August 2014 TRAINING MODULE OBJECTIVES Quality Measurement 101 is a training module for providers who are interested in learning
ACCOUNTABLE CARE ORGANIZATION (ACO): SUPPLYING DATA AND ANALYTICS TO DRIVE CARE COORDINATION, ACCOUNTABILITY AND CONSUMER ENGAGEMENT
ACCOUNTABLE CARE ORGANIZATION (ACO): SUPPLYING DATA AND ANALYTICS TO DRIVE CARE COORDINATION, ACCOUNTABILITY AND CONSUMER ENGAGEMENT MESC 2013 STEPHEN B. WALKER, M.D. CHIEF MEDICAL OFFICER METRICS-DRIVEN
Updates from CMS: Value-Based Purchasing, ACOs, and Other Initiatives The Seventh National Pay for Performance Summit March 19, 2012
Updates from CMS: Value-Based Purchasing, ACOs, and Other Initiatives The Seventh National Pay for Performance Summit March 19, 2012 Presenters David Sayen, CMS Regional Administrator Betsy L. Thompson,
Strengthening Community Health Centers. Provides funds to build new and expand existing community health centers. Effective Fiscal Year 2011.
Implementation Timeline Reflecting the Affordable Care Act 2010 Access to Insurance for Uninsured Americans with a Pre-Existing Condition. Provides uninsured Americans with pre-existing conditions access
Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 Reporting Year
Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 Reporting Year Release Notes/Summary of Changes (February 2015): Issued correction of 2014 benchmarks for ACO-9 and ACO-10 quality
Accountable Care Organizations An Operational Overview
Accountable Care Organizations An Operational Overview Chris Champ Principal cchamp@eidebailly.com 701-239-8620 1 Medicare Spending 2 1 CMS Goal Transition of Risk 60 50 40 30 20 10 0 2015 2016 2018 Percentage
12/5/2014. What is PQRS? Performance Measurement Committee Practical Theater. Historical concerns with the program (continued)
What is PQRS? Navigating CMS Quality Initiatives: How to Successfully Report and Avoid Payment Adjustments Performance Measurement Committee Practical Theater A federally mandated Medicare Part B quality
Understanding your. Medicare options. Medicare Made Clear TM. Get Answers Series. Y0066_120629_084915 CMS Accepted
Understanding your Medicare options. Medicare Made Clear TM Get Answers Series Y0066_120629_084915 CMS Accepted learning about Medicare Choices. Eligibility Coverage options When to enroll Next steps and
Kaiser Permanente Guide to Medicare Basics
Kaiser Permanente Guide to Medicare Basics The National Medicare program, which was created in 1965, has given people peace of mind and the security of knowing they ll have access to health coverage. Medicare
4040 McEwen Rd. Suite 350. Dallas. TX 75244 972-503-3215 * fax 972-503-3219 * info@nw 14.esrd.net * www.esrdnetwork.org
4040 McEwen Rd. Suite 350. Dallas. TX 75244 972-503-3215 * fax 972-503-3219 * info@nw 14.esrd.net * www.esrdnetwork.org STANDARD 1 ESRD NETWORK #14 MEDICAL REVIEW BOARD STANDARDS FOR THE REGISTERED NURSE
Tips from Social Workers for Kidney Patients
Tips from Social Workers for Kidney Patients The Ohio State University Medical Center provides a social worker to work closely with you while you are in the hospital during the acute and chronic phases
DSRIP, Shared Savings, and the Path towards Value Based Payment
Redesign Medicaid in New York State DSRIP, Shared Savings, and the Path towards Value Based Payment New York State Department of Health New York, New York The DSRIP Challenge Transforming the Delivery
Managing End-Stage Renal Disease Improving clinical outcomes and reducing the cost of care for Medicare Advantage, Medicaid and Commercial Populations
White Paper Managing End-Stage Renal Disease Improving clinical outcomes and reducing the cost of care for Medicare Advantage, Medicaid and Commercial Populations Optum www.optum.com Page 1 Executive Summary
Roadmap for Implementing Value Driven Healthcare in the Traditional Medicare Fee-for-Service Program
Centers for Medicare & Medicaid Services Roadmap for Implementing Value Driven Healthcare in the Traditional Medicare Fee-for-Service Program vision for america: GOALS FOR VALUE-BASED PURCHASING: Patient-centered,
MACRA & APMs: More than Acronyms June 2, 2016
MACRA & APMs: More than Acronyms June 2, 2016 Agenda 1. Framework 2. CMS Quality Initiatives 3. MACRA - MIPS or APM? 4. Alternative Payment Models 5. Case Study 2 Alternative Payment Models Transitioning
MEDICARE 101 A Webinar presented by Keenan & Associates and Kaiser Permanente
MEDICARE 101 A Webinar presented by Keenan & Associates and Kaiser Permanente Sylvia Weathers Service Consultant Keenan & Associates Nancy C. Voltero Retiree Programs Consultant Kaiser Permanente License
ASN Dialysis Advisory Group ASN DIALYSIS CURRICULUM
ASN Dialysis Advisory Group ASN DIALYSIS CURRICULUM 0 ASN Dialysis Curriculum Staffing in Dialysis Units Gina Randolph, RN, MSN, MBA Affiliations: DaVita, Inc. (employee) 1 What Determines Staffing Needs?
2014 Medicare Physician Fee Schedule Proposed Rule Quality Provisions
2014 Medicare Physician Fee Schedule Proposed Rule Quality Provisions The 2014 Medicare Physician Fee Schedule (MPFS) Notice of Proposed Rulemaking (NPRM) was published in the Federal Register on July